Home > Compound List > Product Information
GSK360A_Molecular_structure_CAS_931399-19-8)
Click picture or here to close

GSK360A

Catalog No. G797600 Name Toronto Research Chemicals
CAS Number 931399-19-8 Website http://www.trc-canada.com
M. F. C17H17FN2O5 Telephone +1 (416) 665-9696
M. W. 348.3256832 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage Refrigerator Chembase ID: 169782

SYNONYMS

IUPAC name
2-{[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl]formamido}acetic acid
IUPAC Traditional name
{[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxoquinolin-3-yl]formamido}acetic acid
Synonyms
N-[[1-(2-Cyclopropylethyl)-6-fluoro-1,2-dihydro-4-hydroxy-2-oxo-3-quinolinyl]carbonyl]glycine
N-[[1-(2-Cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydro-3-quinolinyl]carbonyl]glycine

DATABASE IDS

CAS Number 931399-19-8

PROPERTIES

Certificate of Analysis Download
Apperance Beige Solid
Melting Point 195-197°C
Solubility Methanol
MSDS Link Download
Storage Condition Refrigerator

DETAILS

Description (English)
GSK360A orally active HIF-PHD inhibitor. GSK360A exerts systemic and local effects by stabilizing HIF-1α signaling and improves long-term ventricular function, remodeling, and vascularity in a model of established ventricular dysfunction. These findings s

REFERENCES

  • Bao, W.-K. et al.: J. Cardio. Pharmacol., 56, 147 (2010)